Pacemaker News and Research

RSS

Clinipace Worldwide selected to manage Spectranetics' cardiovascular device clinical study

Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Spectranetics Corporation, a developer, manufacturer, marketer and distributer of single-use medical devices used in minimally invasive procedures within the cardiovascular system, has selected Clinipace to manage all aspects of a pivotal cardiovascular device clinical study that will serve as the basis for 510(k) notice submission.

20 Jul 2011

InterStim Therapy now available for treatment of chronic bowel incontinence

A new procedure is now available for the treatment of chronic bowel incontinence, a disorder impacting the lives of more than 18 million Americans. The treatment, called InterStim Therapy is a minimally invasive procedure which uses electrical impulses to stimulate the sacral nerve and improve muscle function.

19 Jul 2011

New ways for treating diabetes

Surgeons at NewYork-Presbyterian Hospital/Columbia University Medical Center are innovating new ways to treat diabetes using techniques from weight-loss surgery, including experimental procedures to improve blood glucose levels and address a major complication of the disease.

16 Jul 2011

Research roundup: Putting good science into practice; shifting hospital costs; finding savings in Mass.

In 2006, researchers published a widely reported study showing that for many patients who had suffered a heart attack more than 24 hours before and had a blocked coronary artery, certain heart procedures, such as balloon angioplasty and the insertion of stents, were no more effective than drugs alone. In 2007, the American Heart Association and the American College of Cardiology issued guidelines urging doctors to not use such treatments in those patients.

16 Jul 2011

Implantable fuel cells may obtain energy from blood sugar and oxygen

Implants that obtain their energy from blood sugar and oxygen: Dr. Sven Kerzenmacher at the Department of Microsystems Engineering (IMTEK) of the University of Freiburg is researching the development of biological fuel cells with the goal of finding an inexhaustible source of power in the human body. He has been awarded the 2011 FAM Research Prize for his dissertation by the Forum for Applied Microsystems Technology (FAM).

15 Jul 2011

Heart experts begin to test new device for treatment of blocked aortic valves

Heart experts at Johns Hopkins have begun testing a new device designed to replace blocked aortic valves in patients for whom traditional open-heart surgery is considered too risky, such as elderly patients and those with other serious medical conditions.

13 Jul 2011

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.

27 Jun 2011

BIOTRONIK to introduce Lumax DX system for complete atrial arrhythmia diagnosis

BIOTRONIK SE & Co. KG, a worldwide leader in manufacturing cardiac medical devices, announced today that the innovative new Lumax 540 VR-T DX single-chamber implantable cardiac defibrillator (ICD) and Linoxsmart S DX cardiac lead system will be launched this coming week at the EHRA EUROPACE electrophysiology congress in Madrid, Spain.

24 Jun 2011

Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

Ultrasound is often used as a first-line diagnostic exam to quickly and safely diagnose a range of patient conditions. At this year's American Society of Echocardiography (ASE) annual meeting in Montreal, June 11-14, 2011, Toshiba America Medical Systems, Inc., will highlight cardiac and shared service ultrasound applications designed to improve cardiac ultrasound imaging.

13 Jun 2011

Cardiac resynchronization therapy improves sexual health in men with chronic heart failure

A new study published in the journal Clinical Cardiology reveals that in men with chronic heart failure, cardiac resynchronization therapy improves patients' libido, erectile dysfunction, and sexual performance.

2 Jun 2011

Spectranetics to showcase new advanced peripheral atherectomy simulation system at New Cardiovascular Horizons

Spectranetics Corporation today announced it will showcase a new advanced peripheral atherectomy simulation system at the New Cardiovascular Horizons meeting in New Orleans.

31 May 2011

Caffeine reduces muscle activity in Fallopian tubes

Caffeine reduces muscle activity in the Fallopian tubes that carry eggs from a woman's ovaries to her womb. "Our experiments were conducted in mice, but this finding goes a long way towards explaining why drinking caffeinated drinks can reduce a woman's chance of becoming pregnant," says Professor Sean Ward from the University of Nevada School of Medicine, Reno, USA. Ward's study is published today in the British Journal of Pharmacology

24 May 2011

New book provides insight into new stem cell therapies for stabilizing heart function

A new book edited by researchers at Worcester Polytechnic Institute and the Stony Brook University School of Medicine provides a comprehensive look at the science and application of cellular therapies aimed at the leading cause of death---heart disease.

18 May 2011

First non-invasive technique to directly map electrical activation of the heart

Abnormalities in cardiac conduction, the rate at which the heart conducts electrical impulses to contract and relax, are a major cause of death and disability around the world. Researchers at Columbia Engineering School have been developing a new method, Electromechanical Wave Imaging, that is the first non-invasive technique to map the electrical activation of the heart.

10 May 2011

Angel Medical Systems to present observations of ischemic events detected using permanently implanted intracardiac ST-segment monitor in high risk CAD patients

Angel Medical Systems has announced that David Keenan will be presenting on behalf of Mitchell Krucoff, MD, FACC, Chairman, Division of Cardiology, Duke University, Durham, NC, on May 6th, 2011 from 2:45-3:00 PM at the Heart Rhythm Society's 32nd Annual Scientific Sessions at the Moscone Center in San Francisco, California.

5 May 2011

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Two studies to be presented this week address the often-overlooked costs associated with atrial fibrillation, the most common form of cardiac arrhythmia.

5 May 2011

Nation's emergency physicians warn about dangers linked with deep vein thrombosis

As temperatures warm and travel picks up around the country, the nation's emergency physicians issue a warning about the serious dangers associated with deep vein thrombosis.

5 May 2011

First implantation of WiCS wireless cardiac pacing system performed in Germany

EBR Systems, Inc., a privately held clinical stage company, announced today the first human implants of the WiCS Wireless Cardiac Stimulation System.

3 May 2011

FDA approves BIOTRONIK's new Estella and Effecta pacemakers

BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced FDA approval of the new Estella and Effecta pacemakers, as well as advanced new features and technologies for the Evia pacemaker family.

28 Apr 2011

Spectranetics revenue increases 5% to $30.4 million for first quarter 2011

Spectranetics Corporation today reported financial results for the quarter ended March 31, 2011.

27 Apr 2011

Pacemaker News and Research

Clinipace Worldwide selected to manage Spectranetics' cardiovascular device clinical study

InterStim Therapy now available for treatment of chronic bowel incontinence

New ways for treating diabetes

Research roundup: Putting good science into practice; shifting hospital costs; finding savings in Mass.

Implantable fuel cells may obtain energy from blood sugar and oxygen

Heart experts begin to test new device for treatment of blocked aortic valves

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

BIOTRONIK to introduce Lumax DX system for complete atrial arrhythmia diagnosis

Toshiba to highlight cardiac ultrasound applications at ASE annual meeting

Cardiac resynchronization therapy improves sexual health in men with chronic heart failure

Spectranetics to showcase new advanced peripheral atherectomy simulation system at New Cardiovascular Horizons

Caffeine reduces muscle activity in Fallopian tubes

New book provides insight into new stem cell therapies for stabilizing heart function

First non-invasive technique to directly map electrical activation of the heart

Angel Medical Systems to present observations of ischemic events detected using permanently implanted intracardiac ST-segment monitor in high risk CAD patients

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Nation's emergency physicians warn about dangers linked with deep vein thrombosis

First implantation of WiCS wireless cardiac pacing system performed in Germany

FDA approves BIOTRONIK's new Estella and Effecta pacemakers

Spectranetics revenue increases 5% to $30.4 million for first quarter 2011

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News